Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Defra trials gassing as a badger cull option
badger
Defra says no live animals will be used in the trials.
FOI request reveals trials are being carried out on artificial setts

Defra has revealed it has been conducting trials to determine the humaneness and efficacy of gassing as a badger culling option since summer 2013.

Information about the trials has been published online following a freedom of information (FOI) request.

No animals have been used in the investigations, according to Defra. Preliminary tests have been carried out to investigate the dispersal of carbon monoxide in a sett environment. Trials will not involve the use of active setts or testing on live animals.

Nitrogen oxide foam has also been used in an artificial structure but this work is "not being pursued", Defra says.

The aim of the investigation is to determine whether humane and effective outcomes could be achieved using gas in real setts.

Trials are still ongoing and it is currently unknown how long they are expected to last. Defra is withholding the location of the trial to protect the safety and security of staff.

Pilot badger culls in Gloucestershire and Somerset last year aimed to reduce the badger population by 70 per cent as part of the Government's plan to eradicate bovine TB. However, shooters in both areas failed to meet their targets.

Furthermore, a report by an independent expert panel (IEP) revealed the culls failed on both humaneness and effectiveness.

MPs voted against a roll-out of the culls to other areas of the country in a parliamentary debate in March this year. Culls are set to continue in Somerset and Gloucestershire, however, with improvements recommended by the IEP.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.